Gross S D, Schwab M S, Taieb F E, Lewellyn A L, Qian Y W, Maller J L
Department of Pharmacology, Howard Hughes Medical Institute, University of Colorado School of Medicine, Denver, CO 80262-0236, USA.
Curr Biol. 2000 Apr 20;10(8):430-8. doi: 10.1016/s0960-9822(00)00425-5.
During oocyte maturation in Xenopus, progesterone induces entry into meiosis I, and the M phases of meiosis I and II occur consecutively without an intervening S phase. The mitogen-activated protein (MAP) kinase is activated during meiotic entry, and it has been suggested that the linkage of M phases reflects activation of the MAP kinase pathway and the failure to fully degrade cyclin B during anaphase I. To analyze the function of the MAP kinase pathway in oocyte maturation, we used U0126, a potent inhibitor of MAP kinase kinase, and a constitutively active mutant of the protein kinase p90(Rsk), a MAP kinase target.
Even with complete inhibition of the MAP kinase pathway by U0126, up to 90% of oocytes were able to enter meiosis I after progesterone treatment, most likely through activation of the phosphatase Cdc25C by the polo-like kinase Plx1. Subsequently, however, U0126-treated oocytes failed to form metaphase I spindles, failed to reaccumulate cyclin B to a high level and failed to hyperphosphorylate Cdc27, a component of the anaphase-promoting complex (APC) that controls cyclin B degradation. Such oocytes entered S phase rather than meiosis II. U0126-treated oocytes expressing a constitutively active form of p90(Rsk) were able to reaccumulate cyclin B, hyperphosphorylate Cdc27 and form metaphase spindles in the absence of detectable MAP kinase activity.
The MAP kinase pathway is not essential for entry into meiosis I in Xenopus but is required during the onset of meiosis II to suppress entry into S phase, to regulate the APC so as to support cyclin B accumulation, and to support spindle formation. Moreover, one substrate of MAP kinase, p90(Rsk), is sufficient to mediate these effects during oocyte maturation.
在非洲爪蟾卵母细胞成熟过程中,孕酮诱导细胞进入减数分裂I,减数分裂I和II的M期连续发生,中间没有S期。丝裂原活化蛋白(MAP)激酶在减数分裂开始时被激活,有人提出M期的连续性反映了MAP激酶途径的激活以及在减数分裂后期I期间细胞周期蛋白B未能完全降解。为了分析MAP激酶途径在卵母细胞成熟中的功能,我们使用了U0126,一种有效的MAP激酶激酶抑制剂,以及蛋白激酶p90(Rsk)的组成型活性突变体,p90(Rsk)是一种MAP激酶靶点。
即使U0126完全抑制MAP激酶途径,高达90%的卵母细胞在孕酮处理后仍能进入减数分裂I,最有可能是通过polo样激酶Plx1激活磷酸酶Cdc25C。然而,随后,经U0126处理的卵母细胞未能形成减数分裂I中期纺锤体,未能将细胞周期蛋白B重新积累到高水平,也未能使Cdc27过度磷酸化,Cdc27是控制细胞周期蛋白B降解的后期促进复合物(APC)的一个组成部分。这些卵母细胞进入S期而非减数分裂II。在没有可检测到的MAP激酶活性的情况下,表达组成型活性形式的p90(Rsk)的经U0126处理的卵母细胞能够重新积累细胞周期蛋白B,使Cdc27过度磷酸化并形成中期纺锤体。
MAP激酶途径对于非洲爪蟾卵母细胞进入减数分裂I不是必需的,但在减数分裂II开始时是必需的,以抑制进入S期,调节APC以支持细胞周期蛋白B的积累,并支持纺锤体形成。此外,MAP激酶的一个底物p90(Rsk)在卵母细胞成熟过程中足以介导这些效应。